Print

Trinity Biotech (TRIB) Announces Details of Its Dividend and Share Buyback Program  
6/6/2012 9:51:26 AM

DUBLIN, Ireland, June 6, 2012 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, announced additional details of its Dividend and Share Buyback Program.
//-->